688613 奥精医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.6574.0407.47612.93915.390
总资产报酬率 ROA (%)0.5973.6336.60010.82811.695
投入资产回报率 ROIC (%)0.6273.8477.04512.03713.192

边际利润分析
销售毛利率 (%)76.73582.67583.37685.35383.806
营业利润率 (%)5.26821.63339.26457.15055.609
息税前利润/营业总收入 (%)3.65421.62637.70855.58556.398
净利润/营业总收入 (%)4.93123.38737.38250.01747.407

收益指标分析
经营活动净收益/利润总额(%)-42.46932.63381.25085.26892.365
价值变动净收益/利润总额(%)166.58536.70010.62911.2984.432
营业外收支净额/利润总额(%)-3.2240.204-0.119-2.167-0.108

偿债能力分析
流动比率 (X)25.34323.64123.57420.3157.767
速动比率 (X)24.62322.99723.19619.9707.460
资产负债率 (%)7.5418.0339.14910.90419.038
带息债务/全部投入资本 (%)2.6692.6582.2343.184--
股东权益/带息债务 (%)3,580.1353,593.5134,249.5862,937.2042,909.337
股东权益/负债合计 (%)1,211.4481,127.201975.982800.203406.317
利息保障倍数 (X)-2.520-418.870-24.990-157.26266.398

营运能力分析
应收账款周转天数 (天)130.84578.01048.96535.3810.000
存货周转天数 (天)259.643234.048164.822213.0860.000